The system is designed to shorten scan times, which may be better for people who struggle to stay still or have ...

Curis, Inc. ("Curis") , a biotechnology company focused on the development of emavusertib (CA-4948), an orally available, small molecule IRAK4 inhibitor, today reported its business update and ...

Axonal's Agentic AI Collaborative Workspace leverages multi-agent technology to shorten the time from insights to actions and ...

This multifaceted inhibition improves synaptic transmission and axonal transport, reduces neuroinflammation, and... corporate communications solutions . With broad reach and a seasoned team of ...

Karl Fitzpatrick has described his frightening ordeal after being diagnosed with potentially life-threatening Guillain–Barré ...